Compound ID | 2811
Class: Natural product antibiotic
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against methicillin-resistant Staphylococcus aureus; antibiotic resistance determinant Cfr inhibitor (Cfr-dependent activity; inhibits methylation of residue A2503 of 23S rRNA) |
| Description: | Natural product from Streptomyces WAC01849; potentiates PhLOPSa antibiotics (not observed when cfr is absent); speculated to be intermediate product of a kiamycin-like compound |
| Institute where first reported: | Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/mbio.01791-23 |